InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
68,973.11
(
0.65%
)
Post# of 251939
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

northern vortex

Send PM Follow Ignore
Followers 1
Posts 59
Boards Moderated 0
Alias Born 01/17/2017

northern vortex

Re: ronpopeil post# 223288

Sunday, 01/27/2019 2:43:09 PM

Sunday, January 27, 2019 2:43:09 PM

Post# of 251939
Ron – regarding AUPH’s recent DES results – I suggest that one go directly to the study results released by AUPH rather than rely on the loaded spin supplied by AF in STATNEWS; which appears to be endorsed by you. I wouldn’t call results demonstrating statistically greater efficacy “a flop”. Furthermore, I couldn’t find any difference in tolerability between treatments in the AUPH NR, as stated in the STATNEWS article.

https://ir.auriniapharma.com/press-releases/detail/131/aurinia-announces-voclosporin-ophthalmic-solution

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up